Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 1
2002 2
2004 1
2007 1
2008 2
2009 1
2010 1
2011 1
2012 6
2013 4
2014 7
2015 5
2016 6
2017 10
2018 9
2019 10
2020 13
2021 16
2022 16
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
Jenkins DJA, Dehghan M, Mente A, Bangdiwala SI, Rangarajan S, Srichaikul K, Mohan V, Avezum A, Díaz R, Rosengren A, Lanas F, Lopez-Jaramillo P, Li W, Oguz A, Khatib R, Poirier P, Mohammadifard N, Pepe A, Alhabib KF, Chifamba J, Yusufali AH, Iqbal R, Yeates K, Yusoff K, Ismail N, Teo K, Swaminathan S, Liu X, Zatońska K, Yusuf R, Yusuf S; PURE Study Investigators. Jenkins DJA, et al. N Engl J Med. 2021 Apr 8;384(14):1312-1322. doi: 10.1056/NEJMoa2007123. Epub 2021 Feb 24. N Engl J Med. 2021. PMID: 33626252
Regulatory effects of trimetazidine in cardiac ischemia/reperfusion injury.
Farzaei MH, Ramezani-Aliakbari F, Ramezani-Aliakbari M, Zarei M, Komaki A, Shahidi S, Sarihi A, Salehi I. Farzaei MH, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1633-1646. doi: 10.1007/s00210-023-02469-7. Epub 2023 Mar 27. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36971866 Review.
Ischemia/reperfusion (I/R) injury is a tissue damage during reperfusion after an ischemic condition. ...Recently, there are evidence, which miRNAs are the major modulators of cardiovascular diseases, especially myocardial I/R injury. Cardiovascular miRNAs, specifica …
Ischemia/reperfusion (I/R) injury is a tissue damage during reperfusion after an ischemic condition. ...Recently, there are evidence, …
Graph-based abstractive biomedical text summarization.
Givchi A, Ramezani R, Baraani-Dastjerdi A. Givchi A, et al. J Biomed Inform. 2022 Aug;132:104099. doi: 10.1016/j.jbi.2022.104099. Epub 2022 Jun 11. J Biomed Inform. 2022. PMID: 35700914 Free article.
Animal models of atherosclerosis.
Kapourchali FR, Surendiran G, Chen L, Uitz E, Bahadori B, Moghadasian MH. Kapourchali FR, et al. World J Clin Cases. 2014 May 16;2(5):126-32. doi: 10.12998/wjcc.v2.i5.126. World J Clin Cases. 2014. PMID: 24868511 Free PMC article. Review.
This mouse model of hypercholesterolemia and atherosclerosis has been also used to investigate the impact of oxidative stress and inflammation on atherogenesis. Low density lipoprotein (LDL)-r-KO mice are a model of human familial hypercholesterolemia. However, unlike apo …
This mouse model of hypercholesterolemia and atherosclerosis has been also used to investigate the impact of oxidative stress and inflammati …
Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients.
Mazaherpour H, Sofian M, Farahani E, Abdi A, Mazaherpour S, Bavand A, Ramezani A. Mazaherpour H, et al. Biomed Res Int. 2022 Jan 7;2022:1522426. doi: 10.1155/2022/1522426. eCollection 2022. Biomed Res Int. 2022. PMID: 35013710 Free PMC article.
One group received ATV/r plus hydroxychloroquine, and the other group received hydroxychloroquine plus LPV/r. ...Our findings showed a significant increase in bilirubin in ATV/r-receiving group compared to LPV/r receivers. There was also a significant …
One group received ATV/r plus hydroxychloroquine, and the other group received hydroxychloroquine plus LPV/r. ...Our findings …
The Microbiome and p-Inulin in Hemodialysis: A Feasibility Study.
Raj DS, Sohn MB, Charytan DM, Himmelfarb J, Ikizler TA, Mehrotra R, Ramezani A, Regunathan-Shenk R, Hsu JY, Landis JR, Li H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium. Raj DS, et al. Kidney360. 2021 Jan 15;2(3):445-455. doi: 10.34067/KID.0006132020. eCollection 2021 Mar 25. Kidney360. 2021. PMID: 35369018 Free PMC article.
109 results